GL1X · GenesisL1 explorer

MolNFT v1 · #133931 · protein

Pandda analysis group deposition -- crystal structure of SARS-cov-2 NSP14 in complex with Z1310876699

5SLW · Proofreading exoribonuclease NSP14: “Pandda analysis group deposition -- crystal structure of SARS-cov-2 NSP14 in complex with Z1310876699”. X-ray diffraction, 3 ligands (U0V, ZN, PO4), 6 pockets (best druggability 0.69). MolNFT v1…

PDB
5SLW
Type
protein
Length
459 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Proofreading exoribonuclease NSP14
EC
3.1.13.-
UniProt
P0DTD1
Ligands
U0V, ZN, PO4
Pockets
6 · best druggability 0.69

Structure

x-ray diffraction · 1 distinct chain · 29% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
DProofreading exoribonuclease NSP14 (EC 3.1.13.-)protein45929% helix, 21% strandP0DTD1

Ligands and binding sites

  • U0V · 2-fluoro-N-[2-(pyridin-4-yl)ethyl]benzamide · ligand · 2 copies · chains D
  • ZN · Zinc ion · metal · 3 copies · chains D
  • PO4 · Phosphate ion · ion · 2 copies · chains D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14240.690.8136U0V
21810.480.7629U0V
3700.380.7821PO4
4590.320.7613empty
5640.320.7511PO4

Compared structures

  • 5SLW · PanDDA analysis group deposition -- Crystal Structure of SARS-CoV-2 NSP14 in complex with… · the same entry in another collection · chain D against D, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.